(HealthDay)—For vulnerable older patients with ovarian cancer, single-agent carboplatin is less active, with worse survival, than combination carboplatin-paclitaxel regimens, according to a study published online April […]
(HealthDay)—Black and Hispanic or Latinx participants are underrepresented in clinical trials for ophthalmology drugs, according to a study published online April 22 in JAMA Ophthalmology.
(HealthDay)—One in three children hospitalized with COVID-19 experience severe illness, which is associated with younger children, male patients, and those with a chronic condition, according to […]